These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33504278)

  • 1. Efficacy and safety of DOACs in patients with peripheral arterial disease: A systematic review and meta-analysis.
    Zhang YS; Chen JH; Mei T; Li S; Lu YM
    Vascular; 2021 Dec; 29(6):846-855. PubMed ID: 33504278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases.
    Savarese G; Reiner MF; Uijl A; D'Amario D; Agewall S; Atar D; Baumgartner I; Borghi C; De Carlo M; Drexel H; Kaski JC; Kjeldsen KP; Kucher N; Lund LH; Niessner A; Semb AG; Schmidt TA; Sulzgruber P; Tamargo J; Vitale C; Wassmann S; Aboyans V; Lewis BS
    Eur Heart J Cardiovasc Pharmacother; 2020 Apr; 6(2):86-93. PubMed ID: 31392312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Rivaroxaban Therapy for Patients With Peripheral Artery Disease: A Systematic Review and Meta-Analysis.
    Hao Y; Han W; Mou D; Wang J
    Vasc Endovascular Surg; 2021 Oct; 55(7):712-720. PubMed ID: 34032469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of Xa inhibitors in patients with heart failure and coronary or peripheral artery disease: a systematic review and meta-analysis of randomized controlled trials.
    Chen Y; Feng X; Qi C; Zhou L; Sun Y; Gu Z; Li X
    Ann Palliat Med; 2021 Jul; 10(7):8082-8093. PubMed ID: 34353093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of direct oral anticoagulants plus aspirin in symptomatic lower extremity peripheral arterial disease: a systematic review and meta-analysis of randomized controlled trials.
    Costa G; Gonçalves L; Teixeira R
    J Thromb Thrombolysis; 2021 Oct; 52(3):904-913. PubMed ID: 33704652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis.
    Giustozzi M; Agnelli G; Del Toro-Cervera J; Klok FA; Rosovsky RP; Martin AC; Herold J; Tzoran I; Szmit S; Bertoletti L; Becattini C; Huisman MV
    Thromb Haemost; 2020 Jul; 120(7):1128-1136. PubMed ID: 32365386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Oral Anticoagulants Combined with Antiplatelet Therapy in the Treatment of Coronary Heart Disease: An Updated Meta-analysis.
    Liu L; Lei H; Hu J; Tang Y; Xu D
    Drugs; 2021 Nov; 81(17):2003-2016. PubMed ID: 34731462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct oral anticoagulants for thromboprophylaxis in ambulatory patients with cancer.
    Wang Y; Wang M; Ni Y; Liang Z
    Hematology; 2020 Dec; 25(1):63-70. PubMed ID: 31984870
    [No Abstract]   [Full Text] [Related]  

  • 10. Rivaroxaban in Peripheral Artery Disease after Revascularization.
    Bonaca MP; Bauersachs RM; Anand SS; Debus ES; Nehler MR; Patel MR; Fanelli F; Capell WH; Diao L; Jaeger N; Hess CN; Pap AF; Kittelson JM; Gudz I; Mátyás L; Krievins DK; Diaz R; Brodmann M; Muehlhofer E; Haskell LP; Berkowitz SD; Hiatt WR
    N Engl J Med; 2020 May; 382(21):1994-2004. PubMed ID: 32222135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct oral anticoagulants for cancer-associated venous thromboembolism: a systematic review and meta-analysis.
    Mulder FI; Bosch FTM; Young AM; Marshall A; McBane RD; Zemla TJ; Carrier M; Kamphuisen PW; Bossuyt PMM; Büller HR; Weitz JI; Middeldorp S; van Es N
    Blood; 2020 Sep; 136(12):1433-1441. PubMed ID: 32396939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Anticoagulant and Antiplatelet Therapy for Peripheral Arterial Disease: A Meta-analysis of Randomized Controlled Trials.
    Tang T; Zhang M; Li W; Hu N; Du X; Ran F; Li X
    Clin Appl Thromb Hemost; 2021; 27():1076029621996810. PubMed ID: 33783251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-Analysis.
    Chen HY; Ou SH; Huang CW; Lee PT; Chou KJ; Lin PC; Su YC
    Clin Drug Investig; 2021 Apr; 41(4):341-351. PubMed ID: 33709339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety.
    Hiatt WR; Bonaca MP; Patel MR; Nehler MR; Debus ES; Anand SS; Capell WH; Brackin T; Jaeger N; Hess CN; Pap AF; Berkowitz SD; Muehlhofer E; Haskell L; Brasil D; Madaric J; Sillesen H; Szalay D; Bauersachs R
    Circulation; 2020 Dec; 142(23):2219-2230. PubMed ID: 33138628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Review and Meta-Analysis on the Efficacy and Safety of Direct Oral Anticoagulants in Patients with Peripheral Artery Disease.
    Peppas S; Sagris M; Bikakis I; Giannopoulos S; Tzoumas A; Kokkinidis DG; Ahmed Z; Korosoglou G; Malgor EA; Malgor RD
    Ann Vasc Surg; 2022 Mar; 80():1-11. PubMed ID: 34644644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding and thrombotic outcomes associated with postoperative use of direct oral anticoagulants after open peripheral artery bypass procedures.
    Obi AT; Thompson JR; Beaulieu RJ; Sutzko DC; Osborne N; Albright J; Gallagher KA; Henke PK
    J Vasc Surg; 2020 Dec; 72(6):1996-2005.e4. PubMed ID: 32278573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
    Alhousani M; Malik SU; Abu-Hashyeh A; Poznanski NJ; Al-Hasan S; Roth DF; Alsharedi M; Mustafa B
    Thromb Res; 2021 Feb; 198():103-114. PubMed ID: 33310644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness and safety of DOACs vs. VKAs in treatment of left ventricular thrombus- a meta-analysis update.
    Hu T; Chen C; Maduray K; Han W; Chen T; Zhong J
    Thromb J; 2024 Mar; 22(1):23. PubMed ID: 38429631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer: a systematic review and meta-analysis.
    Dong Y; Wang Y; Ma RL; Liu M; Gao JZ; Su WY; Yan L; Sun JJ
    J Thromb Thrombolysis; 2019 Oct; 48(3):400-412. PubMed ID: 31062143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Direct Oral Anticoagulant in Addition to Antiplatelet Therapy After Acute Coronary Syndrome: A Systemic Review and Meta-analysis of 53,869 Patients.
    Alharbi A; Mhanna M; Alyosif M; Pena C; Jabr A; Alsughayer A; Alfatlawi H; Safi M; Aldhafeeri A; Patel N; Khuder S; Eltahawy E
    Clin Ther; 2024 Jan; 46(1):e1-e6. PubMed ID: 37880055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.